\n \n \n “. concat(self. i18n. t(‘search. voice. recognition_retry’), “\n
The more infectious subvariant BA. 5 omicron now accounts for nearly 80% of new COVID-19 cases in the United States, as case rates continue to rise.
About 78% of coronavirus cases in the United States are through subpromotion BA. 5, according to the most recent data from the Centers for Disease Control and Prevention (CDC).
The emergence of BA. 5 has raised concerns about its increased ability to evade coverage presented by vaccines and past infections of other variants. Currently, available vaccines are still considered effective in reducing the threat of hospitalizations and deaths from BA. 5, however, the vaccine’s ability to avoid infection appears to be less potent than this subvariant.
President Biden, 79, announced Thursday that he was tested for COVID-19 for the first time. You are fully vaccinated with two more booster doses.
BA. 5, the dominant subpropatrix in the United States earlier this month, overtaking BA. 2. 12. 1. The BA. 4 omicron subvariant is the most prevalent moment with 12. 8% of the cases originating from the pathogen, while the BA. 2. 12. 1 subvariant represents only 8. 6%.
While the prevalence of BA. 5 has increased, the rate of COVID-19 infections has begun to rise again. The case rate had stagnated for several weeks, and the seven-day moving average for daily instances soared around 100,000 for much of June.
This measure began to accumulate from July and now amounts to around 126,000.
While vaccine brands like Pizer and Moderna say they’re running an updated vaccine that, in particular, targets BA. 5, some fitness experts say a new subvariant may be dominant until the updated dose is ready.
This has led to calls to fund the progression of the next generation of COVID-19 vaccines, adding an imaginable “pan-coronavirus” vaccine that would be “variant-proof. “
“It’s critical that we get more resources, otherwise we’re not going to take on the challenge that’s inevitable,” Anthony Fauci, Biden’s top medical adviser, said this week.
“We want the next generation of vaccines, especially mucosal vaccines that would work much better. “
For news, weather, sports, and video streaming, head to The Hill.